Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Aug 27, 16:00
Avadel Pharmaceuticals Cash from Financing (Quarterly) : 2.636M for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 2.636M |
| June 30, 2025 | 1.045M |
| March 31, 2025 | 0.69M |
| December 31, 2024 | 0.4956M |
| September 30, 2024 | 1.390M |
| June 30, 2024 | 0.6674M |
| March 31, 2024 | 13.19M |
| December 31, 2023 | -22.93M |
| September 30, 2023 | 30.61M |
| June 30, 2023 | 96.84M |
| March 31, 2023 | 34.44M |
| December 31, 2022 | 6.789M |
| September 30, 2022 | 10.03M |
| June 30, 2022 | -0.0516M |
| March 31, 2022 | 2.009M |
| December 31, 2021 | -0.0044M |
| September 30, 2021 | 0.1097M |
| June 30, 2021 | 0.0001M |
| March 31, 2021 | 0.149M |
| December 31, 2020 | 0.9732M |
| September 30, 2020 | 7.457M |
| June 30, 2020 | 117.27M |
| March 31, 2020 | 62.21M |
| December 31, 2019 | -0.0405M |
| September 30, 2019 | -0.0409M |
| Date | Value |
|---|---|
| June 30, 2019 | -0.0373M |
| March 31, 2019 | 0.092M |
| December 31, 2018 | -1.004M |
| September 30, 2018 | -1.463M |
| June 30, 2018 | -11.48M |
| March 31, 2018 | 122.92M |
| December 31, 2017 | -5.981M |
| September 30, 2017 | -4.777M |
| June 30, 2017 | -13.17M |
| March 31, 2017 | -0.406M |
| December 31, 2016 | 0.285M |
| September 30, 2016 | -0.5578M |
| June 30, 2016 | -0.4969M |
| March 31, 2016 | -6.979M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | -0.079M |
| December 31, 2014 | 7.333M |
| September 30, 2014 | 2.117M |
| June 30, 2014 | 0.8766M |
| March 31, 2014 | 80.07M |
| December 31, 2013 | 4.264M |
| September 30, 2013 | -0.0169M |
| June 30, 2013 | 0.1682M |
Cash From Financing Definition
Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | -994.50M |
| Perrigo Co. Plc | -388.90M |
| GH Research Plc | 111.51M |
| Cosmo NV | -- |
| Alkermes Plc | 17.20M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 23.27M |
| Cash from Investing (Quarterly) | -8.788M |